A record of what Jaiprakash Toshniwal said publicly, with the source. Not advice.
Pending — not yet graded
“Bullish on the Pharma sector, anticipating its revival to contribute to a stronger market rebound in FY27. This sector, along with banking and IT, is expected to drive lower double-digit earnings growth for the broader market.”
Nifty PharmaBullishCalled 12 Nov 2025
This call has no verdict yet — it is graded HIT or MISS against real price data once a close decides it. Save it above to find it again from your profile.
Read the original articleSee Jaiprakash Toshniwal’s full track record